Heteroaromatic compounds as bruton's tyrosine kinase (BTK) inhibitors

The present invention encompasses compounds of the formula (I) wherein the groups A, Cy, X1 and Y are defined herein, which are suitable for the treatment of diseases related to BTK, process of making, pharmaceutical preparations which contain compounds and their methods of use.

Saved in:
Bibliographic Details
Main Authors BOSANAC TODD, DISALVO DARREN TODD, ZINDELL RENEE M
Format Patent
LanguageEnglish
Published 31.01.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention encompasses compounds of the formula (I) wherein the groups A, Cy, X1 and Y are defined herein, which are suitable for the treatment of diseases related to BTK, process of making, pharmaceutical preparations which contain compounds and their methods of use.
Bibliography:Application Number: AP20150008203